Analysis of TGF-β and TGF-β-RII in thyroid neoplasms from the United States, Japan, and China

Endocrine Pathology

Volumn 9, Issue 3, 1998, Pages 209-216

  Imamura, Yoshiaki ^a,b   Jin, Long ^a   Grande, Joseph P ^a   Li, Chin Yang ^a   Zheng, T R ^c   Erickson, Lori A ^a   Lloyd, Ricardo V ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF FUKUI   (Japan)

^c Fujian Tumor Hospital   (China)

Author keywords

In situ hybridization; Riboprobe; TGF ; TGF RII; Thyroid

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

ANAPLASTIC CARCINOMA; ARTICLE; CHINA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; JAPAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; UNITED STATES;

EID: 0031763010     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02739960     Document Type: Article

References (31)

1. Filmus J, Kerbel RS. Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-β during tumor progression. Curr Opin Oncol 5:123-129, 1993.
2. Lin HY, Wang X-F, Ng-Eaton E, Weinberg RA, Lodish HF. Expression cloning of the TGFβ type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785, 1992.
3. Franzen P, ten Dijke P, Ichijo H, Yamashita H, Schultz P, Heldin C-H, Miyazono K. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 75:681-692, 1993.
4. Bassing CH, Yingling JM, Howe DJ, Wang T, He WW, Gustafson ML, Shah P, Donahoe PK, Wang X-F. A transforming growth factor β type I receptor that signals to activate gene expression. Science 263:87-89, 1994.
5. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of TGF-β receptor. Nature 370:341-347, 1994.
6. Lopez-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massague J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system. Cell 67:785-795, 1991.
7. Wang XF, Lin HY, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA. Expression cloning and characterization of the TGFβ type III receptor. Cell 67:797-805, 1991.
8. Tsushima T, Arai M, Saji M, Ohba Y, Murakami H, Ohmura E, Sato K, Shizume K. Effects of transforming growth factor-β on deoxyribonucleic acid synthesis and iodine metabolism in porcine thyroid cells in culture. Endocrinology 123:1187-1194, 1988.
9. Colletta G, Cirafici AM, Di Carlo A. Dual effect of transforming growth factor β on rat thyroid cells: inhibition of thyrotropin-induced proliferation and reduction of thyroid-specific differentiation markers. Cancer Res 49:3457-3462, 1989.
10. Grubeck-Loebenstein B, Buchan G, Sadeghi R, Kissonerghis M, Londei M, Turner M, Pirich K, Roka R, Niederle B, Kassal H, Walhausl W, Feldman M. Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter. J Clin Invest 83:764-770, 1989.
11. Blaydes JP, Wynford-Thomas D. Loss of responsiveness to transforming growth factor β (TGFβ) is tightly linked to tumorigenicity in a model of thyroid tumor progression. Int J Cancer 65:525-530, 1996.
12. Morosini PP, Taccaliti A, Montironi R, Scarpelli M, Diamanti L, Simonella G, Mancini V, Petrelli MD, Mantero F. TGF-β1 immunohistochemistry in goiter: comparison of patients with recurrence or no recurrence. Thyroid 6:417-422, 1996.
13. Logan A, Smith C, Becks GP, Gonzalez AM, Phillips ID, Hill DJ. Enhanced expression of transforming growth factor-βl during thyroid hyperplasia in rats. J Endocrinol 141: 45-57, 1994.
14. Morosini PP, Taccaliti A, Arnaldi G, Simonella G, Petrelli MD, Mancini V, Montironi R, Scarpelli M, Diamanti L, Mantero F. Enhanced expression of transforming growth factor β1 in rat thyroid hyperplasia is thyrotropin induced and time dependent. Eur J Endocrinol 134:373-378, 1996.
15. Kim IY, Ahn H-J, Zelner DJ, Shaw JW, Sensibor JA, Kim J-H, Kato M, Lee C. Genetic change in transforming growth factor β(TGF-β) receptor type 1 gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res 56:44-48, 1996.
16. Kim IY, Ahn H-J, Zelner DJ, Shaw JW, Lang S, Kato M, Oefelein MG, Miyazono K, Nemeth JA, Kozlowski JM, Lee C. Loss of expression of transforming growth factor β type I and type II receptors correlates with tumor grade in human prostate cancer tissues. Clin Cancer Res 2:1255-1261, 1996.
17. Garrigue-Antar L, Souza RF, Vellucci VF, Meltzer SJ, Reiss M. Loss of transforming growth factor-β type II receptor gene expression in primary human esophageal cancer. Lab Invest 75:263-272, 1996.
18. Garrigue-Antar L, Munoz-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF, Reiss M. Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous cell carcinoma cells. Cancer Res 55:3982-3987, 1995.
19. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JKV. Inactivation of the type II IGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338, 1995.
20. Park K, Kim S-J, Bang Y-J, Park J-G, Kim NK, Roberts AB, Sporn MR. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 91:8772-8776, 1994.
21. Sun L, Wu G, Willson JKV, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang X-F, Brattain MG. Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269:26,449-26,455, 1994.
22. Lazzereschi D, Ranieri A, Mincione G, Taccogna S, Nardi F, Collecta G. Human malignant thyroid tumors displayed reduced levels of transforming growth factor β receptor type II messenger RNA and protein. Cancer Res 57:2071-2076, 1997.
23. Hedigar C, Williams ED, Sobin LH. Histological typing of thyroid tumors: 2nd Ed. Berlin: Springer-Verlag, 1988.
24. Kip1 expression in nontumorous and neoplastic human pituitaries. Am J Pathol 151:509-519, 1997.
25. Lloyd RV, Jin L. In situ hybridization analysis of chromogranin A and B mRNAs in neuroendocrine tumors with digoxigenin-labeled oligonucleotide probe cocktails. Diagn Mol Pathol 4:143-151, 1995.
26. Morosini P, Taccaliti A, Di Loreto G, Arnaldi G, Faloia H, Giacchetti G, Mantero F. Transforming growth factor-beta 1 is more expressed in thyroid follicular adenoma than in normal tissue. J Endocrinol Invest 17:335-340, 1994.
27. Jasani B, Wyllie FS, Wright PA, Lemoine NR, Williams ED, Wynford-Thomas D. Immunocytochemically detectable TGFβ associated with malignancy in thyroid epithelial neoplasia. Growth Factors 2:149-155, 1990.
28. Van der Laan BFAM, Freeman JL, Asa SL. Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues. Thyroid 5:67-73, 1995.
29. kip1 expression in papillary thyroid carcinomas. Endocr Pathol 8:293-300, 1997.
30. Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC. Association of transforming growth factor-β1 with prostatic cancer: an immunohistochemical study. Hum Pathol 24:4-9, 1993.
31. Henriksen R, Gobl A, Wilander E, Öberg K, Miyazono K, Funa K. Expression and prognostic significance of TGF-β isotypes, latent TGK-β1 binding protein, TGF-β type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms. Lab Invest 73:213-220, 1995.